Resmed (RMD) Income from Continuing Operations (2009 - 2026)

Resmed's Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 398732000.0 for Q1 2026.

• Quarterly Income from Continuing Operations rose 9.23% year-over-year to 398732000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1519566000.0 (up 15.71% YoY) and the FY2025 annual result came in at 1400723000.0, up 37.2% from the prior year.
• Income from Continuing Operations was 398732000.0 for Q1 2026 at Resmed, up from 392593000.0 in the prior quarter.
• Across five years, Income from Continuing Operations topped out at 398732000.0 in Q1 2026 and bottomed at 179012000.0 in Q1 2022.
• A 5-year average of 284303705.88 and a median of 292236000.0 in 2024 frame the typical range for Income from Continuing Operations.
• Annual changes were most pronounced in 2022 — Income from Continuing Operations jumped 328.1% — and 2023, when it fell 7.16%.
• Resmed's Income from Continuing Operations stood at 224914000.0 in 2022, then fell by 7.16% to 208800000.0 in 2023, then surged by 65.05% to 344622000.0 in 2024, then gained by 13.92% to 392593000.0 in 2025, then grew by 1.56% to 398732000.0 in 2026.
• Business Quant data shows RMD's Income from Continuing Operations at 398732000.0 in Q1 2026, 392593000.0 in Q4 2025, and 348536000.0 in Q3 2025.